Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Crossy who wrote (1114)	1/21/2003 7:56:54 AM
From: JoeinIowa	Respond to of 23958

Crossy, Sales verse R+D spending makes a lot more sense to me since we know that market cap may not be an indicator of whats the stock is worth. A company I know very well spends around 20% of sales on R+D and that is considered very high. 10% may be a better number for electronics companies. If the number starts to head above 20% you would have to wonder if they are not more of a R+D facility and not into making products. Of course on the front end of any new technology development you would expect higher R+D costs. Biotechs of course would have their own percentages which would be very high since most don't have sales. LOL. Joe